ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 674103 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 674103; 2) Community: the network communities that were significantly associated with the response to NSC 674103; 3) Molecule: the relationships between components within communities and NSC 674103; 4) MDR: the compounds that were significantly associated with the NSC 674103.

NSC Compound Enrichment Correlation
NSC 71669 Null 0.0138010872611484 0.092135707
NSC 716951 Null 0.0138010872611484 0.21448266
NSC 720297 Methyl-7.alpha.,12.alpha.-diacetoxy-5.beta.-cholan-24-oate~ -3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spiro-1"-(4"-t-butyl)cyclohexane 0.0138010872611484 0.37626094
NSC 721049 7Z-Plakortide H 0.0138010872611484 0.25663638
NSC 728316 6-(3-Piperazinyl-1-propyl)-5,6-dihydro-2,3-dimethoxy-8,9-met hylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Dihydrochloride 0.0138010872611484 0.32773213
NSC 758423 Amsacrine (USAN) 0.0138010872611484 0.32134753
NSC 109834 Null 0.0138010872611486 0.21510433
NSC 117274 Null 0.0138010872611486 -0.05289665
NSC 15309 2,5-Cyclohexadiene-1,4-dione, 2,5-dimethyl- (9CI) 0.0138010872611486 0.19075916
NSC 269721 Androstan-3-one, 17-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (5.alpha.,17.beta.)- 0.0138010872611486 0.37987628
Total:84  Current:32    [First] [Prev] [Next] [Last]